Key result
Novel biochemical plasma biomarkers in terminal heart failure may predict advanced mortality risk or recovery and are regulated under mechanical circulatory support.
Why the study?
Can novel biochemical plasma biomarkers predict mortality risk or recovery in terminal heart failure patients?
Can novel biochemical plasma biomarkers predict mortality risk or recovery in terminal heart failure patients?
Novel biochemical plasma biomarkers offer potential for predicting mortality and recovery in terminal heart failure, including during mechanical circulatory support.
Answers are grounded in this paper and cite their sources.
Does not yet support routine biomarker use in terminal HF; leaves open need for prospective validation before clinical adoption.
This review summarizes recent findings on novel biochemical plasma biomarkers in terminal heart failure patients, which might predict an advanced mortality risk or even recovery. Moreover, we discussed the regulation of these heart failure-related biomarkers under mechanical circulatory support.
No takes yet. Share an insight, caveat, or question.
Kramer et al. (2011) studied this question. Novel biochemical plasma biomarkers in terminal heart failure may predict advanced mortality risk or recovery and are regulated under mechanical circulatory support.
Synapse has enriched 10 related papers. Consider them for comparative context: